A doctor holds up a package of hydroxychloroquine

Hydroxychloroquine and Type 1 Diabetes?! Why TrialNet Is Looking Into It

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/15349382/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_314_Final_JDRF_Hydroxychloroquine.mp3″ libsyn_item_id=”15349382″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /] Before hydroxychloroquine was part of the national Covid conversation, it was being looked at in studies to see if it might help in the prevention of type 1 diabetes. Recently JDRF held a Facebook Live event with Dr. Jane…

In the News… New research in T1D prevention, fast-acting biosimilar insulin approved, Lilly lowers Zepbound price, and more!

It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: New drug is looked at for T1D prevention, a new stem cell method is tested for beta cell transplanation without immunosuppresion drugs, the FDA okays the first fast-acting biosimilar insulin, Lilly lowers price of Zepbound,…

In the News… Does food-as-medicine work for T2D? Fake Ozempic warning, new Tzield research, My Cause My Cleats and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new study looks at food-as-medicine for type 2, another FDA warning about fake Ozempic, new research says gut markers may help predict who Tzield will work best for, JDRF partners with NFL…

DIABETES CONNECTIONS TYPE 2

Recent Episodes We’ve wrapped up production of this podcast. Please join us each week for the original Diabetes Connections! Stay in touch with our newsletter (sign up here). January 22, 2025 In the News.. Dexcom 15-day sensor update, TrialNet milestone, Beta Bionic IPO, and more! It’s In the News.. a look at the top headlines…